QiMing Venture Partners

Qiming Venture Partners is a venture capital firm in China that focuses on building new companies in the country. Founded 2006 in Shanghai, China, it invests in early stage ventures, late stage ventures, post-IPO, private equity, series C, series B, series D, and series A. Its portfolio companies include Nice Tuan, Cadent Therapeutics, Yunyinggu, Nuohui Health, Abbisko Therapeutics, ShouTi, Singular Medical, NVX Clouds Tech, and Fingo. As of June 2020, Qiming Venture Partners has made 571 investments. Their most recent investment was on May 30, 2020, when Nice Tuan raised $81.4M. Qiming Venture Partners has made 571 investments. Their most recent investment was on May 30, 2020, when Nice Tuan raised $81.4M.